Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages

Archives of Biochemistry and Biophysics
Yingjun Luan, Helen R Griffiths

Abstract

Oxidised LDL accumulates in macrophages following scavenger receptor (SR) uptake. The expression of the SR, CD36, is increased by oxidised LDL. The signalling molecule, ceramide, can modulate intracellular peroxides and increase lipid peroxidation. Ceramide also accumulates in atherosclerotic plaques. Thus, we have examined whether ceramide can modulate CD36 expression and function in human monocyte/macrophages. Addition of synthetic short chain ceramides or the action of sphingomyelinase to generate physiological long chain ceramides in situ caused significant reductions in CD36 expression by monocytes/macrophages which was not due to inhibition of mRNA expression. Inhibition of proteasomal degradation using lactacystin had no effect on CD36 expression, however, flow cytometric analysis of permeabilised cells suggested an intracellular trafficking blockade. Ceramide treated monocytes/macrophages showed dose dependent reduction in oxidised LDL uptake. Taken together, it is suggested that ceramide blocks the transport of CD36 to the membrane of monocytes/macrophages, thereby preventing uptake of oxidised LDL.

References

Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C ZuberK Moremen
Sep 1, 1987·Circulation·D Steinberg
Jan 1, 1986·Methods in Enzymology·B H ChungJ T Cone
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Oct 1, 1995·The Journal of Clinical Investigation·S NozakiK Kameda-Takemura
Jun 2, 1995·The Journal of Biological Chemistry·C S ChenR E Pagano
Jan 19, 1996·The Journal of Biological Chemistry·M AlessioR Sitia
Feb 14, 1998·The Journal of Cell Biology·X ZhaF R Maxfield
Jul 20, 1999·The Journal of Biological Chemistry·R LiS Ladisch
May 29, 2000·The Journal of Biological Chemistry·J M HolopainenP K Kinnunen
Sep 23, 2000·Nature·A J Lusis
Oct 26, 2000·Trends in Cell Biology·K Simons, J Gruenberg
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H P DeignerR Kinscherf
Oct 27, 2001·Acta Physiologica Scandinavica·Y Huo, K Ley
Nov 22, 2001·Circulation Research·T LevadeR Salvayre
Jan 25, 2002·Annals of the New York Academy of Sciences·A C NicholsonD P Hajjar
Feb 14, 2002·Trends in Cardiovascular Medicine·Paavo K J Kinnunen, Juha M Holopainen
May 16, 2002·The Journal of Biological Chemistry·Sarah Spiegel, Sheldon Milstien
Oct 24, 2002·Archives of Biochemistry and Biophysics·Darren Charles PhillipsHelen R Griffiths
Dec 20, 2002·Nature·Peter Libby
Jul 25, 2003·The Biochemical Journal·Darren C Phillips, Helen R Griffiths
Aug 7, 2003·Biochemical and Biophysical Research Communications·Sarah J RaymentHelen R Griffiths
Sep 10, 2004·Current Molecular Medicine·B J PettusY A Hannun
Oct 30, 2004·Circulation Research·Israel F Charo, Mark B Taubman
Mar 23, 2005·Free Radical Biology & Medicine·Adelina MunteanuAngelo Azzi
May 21, 2005·Biochimica Et Biophysica Acta·Jesús SotAlicia Alonso

❮ Previous
Next ❯

Citations

Mar 31, 2011·Journal of Agricultural and Food Chemistry·Yukio FujiwaraTsuyoshi Ikeda
Oct 17, 2009·Journal of Cardiovascular Pharmacology·Yinan HuaNair Sreejayan
Nov 3, 2011·The Journal of Clinical Investigation·Benjamin T Bikman, Scott A Summers
Oct 12, 2013·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·J GertowR M Fisher
Oct 24, 2015·Journal of Cellular and Molecular Medicine·Dimitry A ChistiakovAlexander N Orekhov
Oct 7, 2010·Free Radical Biology & Medicine·Jean-Marc ZinggAngelo Azzi
Jul 30, 2008·Biochimica Et Biophysica Acta·Tzi-Wei LianMing-Jiuan Wu
May 30, 2012·Free Radical Biology & Medicine·Dan GaoHelen R Griffiths
Nov 21, 2007·Biochimica Et Biophysica Acta·C E GallegosF J Barrantes
Nov 22, 2016·PloS One·Stefan WallnerGerd Schmitz
Jan 7, 2017·Journal of Cellular Biochemistry·Jean-Marc ZinggMohsen Meydani
Sep 18, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Yukio FujiwaraRyoji Nagai
Aug 29, 2018·Scientific Reports·Jason M CorrentiRotonya M Carr
Sep 22, 2010·Journal of Natural Products·Toshihiro NoharaMona El-Aasr
Aug 10, 2021·Bioscience, Biotechnology, and Biochemistry·Yukio FujiwaraYoshihiro Komohara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.